AR125221A2 - SGC STIMULATORS - Google Patents
SGC STIMULATORSInfo
- Publication number
- AR125221A2 AR125221A2 ARP220100722A ARP220100722A AR125221A2 AR 125221 A2 AR125221 A2 AR 125221A2 AR P220100722 A ARP220100722 A AR P220100722A AR P220100722 A ARP220100722 A AR P220100722A AR 125221 A2 AR125221 A2 AR 125221A2
- Authority
- AR
- Argentina
- Prior art keywords
- concentration
- increase
- sgc stimulators
- sgc
- stimulators
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente descripción hace referencia a estimuladores de la guanilato ciclasa soluble (sGC), formulaciones farmacéuticas que los comprenden y sus usos, en solitario o en combinación con uno o más agentes adicionales, para el tratamiento de diversas enfermedades, donde sea conveniente un aumento de la concentración de óxido nítrico (NO) y/o un aumento de la concentración de guanosín monofosfato cíclico (cGMP), o una regulación positiva de la vía de NO. Los compuestos son de fórmula (1).The present description refers to stimulators of soluble guanylate cyclase (sGC), pharmaceutical formulations that comprise them and their uses, alone or in combination with one or more additional agents, for the treatment of various diseases, where an increase in the concentration of nitric oxide (NO) and/or an increase in the concentration of cyclic guanosine monophosphate (cGMP), or an upregulation of the NO pathway. The compounds are of formula (1).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662382942P | 2016-09-02 | 2016-09-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR125221A2 true AR125221A2 (en) | 2023-06-28 |
Family
ID=64755068
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102449A AR109568A1 (en) | 2016-09-02 | 2017-09-01 | SGC STIMULATORS |
| ARP220100722A AR125221A2 (en) | 2016-09-02 | 2022-03-25 | SGC STIMULATORS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102449A AR109568A1 (en) | 2016-09-02 | 2017-09-01 | SGC STIMULATORS |
Country Status (2)
| Country | Link |
|---|---|
| AR (2) | AR109568A1 (en) |
| MA (1) | MA46096B1 (en) |
-
2017
- 2017-09-01 MA MA46096A patent/MA46096B1/en unknown
- 2017-09-01 AR ARP170102449A patent/AR109568A1/en unknown
-
2022
- 2022-03-25 AR ARP220100722A patent/AR125221A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR109568A1 (en) | 2018-12-26 |
| MA46096B1 (en) | 2021-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2019001760A2 (en) | Sgc stimulators | |
| CL2019000018A1 (en) | Solid forms of a sgc stimulator. | |
| CL2015002641A1 (en) | Method for the treatment of parkinson's disease. | |
| CO2018004857A2 (en) | Dihydroimidazopirazinone derivatives used in cancer treatment | |
| CL2019001256A1 (en) | Treatment of diseases of the central nervous system (CNS) with stimulants of sgc. | |
| CU20190101A7 (en) | SUBSTITUTED DIAZABICYCLIC IMIDAZOPYRIMIDINES | |
| PH12019501017A1 (en) | Sgc stimulators | |
| PH12020550956A1 (en) | Sgc stimulators | |
| UY36875A (en) | BROMODOMINIUM INHIBITING COMPOSITIONS FOR THE TREATMENT OF VARIOUS DISEASES | |
| BR112016022976A8 (en) | methods for treating hcv | |
| DOP2017000018A (en) | [1,2,4] TRIAZOLO [4,3-B] PIRIDAZINES FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
| CO2023015528A2 (en) | Soluble guanylyl cyclase (sgc) stimulators | |
| AR113145A1 (en) | COMPOSITIONS AND METHODS TO IMPROVE THE USE OF NITROGEN IN A RUMIANT | |
| AR125221A2 (en) | SGC STIMULATORS | |
| UY37166A (en) | NUCLEOSID ALKYLIN ANALOGS AS INHIBITORS OF HUMAN RINOVIRUS | |
| BR112018072255A2 (en) | azasteroids for tuberculosis treatment | |
| AR112841A1 (en) | COMPOSITIONS AND PROCEDURES TO IMPROVE THE USE OF NITROGEN IN A RUMIANT | |
| AR106203A1 (en) | COMBINED THERAPY AND HCV TREATMENT REGIME |